Evidence map›Paper›PMID 41879255›Full record

ArticleThe FEBS journal2026

Tyrosine residues at the substrate binding site in human NQO1 homodimer: Protein conformational dynamics and optimization of substrate binding geometry.

Maribel Rivero, Juan Luis Pacheco-Garcia, Pavla Vankova, Dmitry Loginov, Isabel Quereda-Moraleda, Jose Manuel Martin-Garcia, Petr Man, Angel Luis Pey, Milagros Medina

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maribel RiveroDepartment of Biochemistry and Molecular and Cellular Biology, Faculty of Sciences, University of Zaragoza, Zaragoza, Spain.
Juan Luis Pacheco-GarciaDepartment of Physical Chemistry, Faculty of Sciences, University of Granada, Granada, Spain.
Pavla VankovaInstitute of Biotechnology - BioCeV, Academy of Sciences of the Czech Republic, Vestec, Czech Republic.
Dmitry LoginovInstitute of Microbiology - BioCeV, Academy of Sciences of the Czech Republic, Vestec, Czech Republic.
Isabel Quereda-MoraledaDepartment of Crystallography and Structural Biology, Institute of Physical Chemistry Blas Cabrera, Spanish National Research Council (CSIC), Madrid, Spain.
Jose Manuel Martin-GarciaDepartment of Crystallography and Structural Biology, Institute of Physical Chemistry Blas Cabrera, Spanish National Research Council (CSIC), Madrid, Spain.ORCID https://orcid.org/0000-0002-4558-3858
Petr ManInstitute of Microbiology - BioCeV, Academy of Sciences of the Czech Republic, Vestec, Czech Republic.ORCID https://orcid.org/0000-0002-1485-2197
Angel Luis Pey *Department of Physical Chemistry, Unit of Excellence in Chemistry applied to Biomedicine and Environment and Institute of Biotechnology, University of Granada, Granada, Spain.ORCID https://orcid.org/0000-0001-7706-3243
Milagros MedinaDepartment of Biochemistry and Molecular and Cellular Biology, Faculty of Sciences, University of Zaragoza, Zaragoza, Spain.ORCID https://orcid.org/0000-0001-8743-0182

Funding

Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía P18-RT-2413Departamento de Educación, Cultura y Deporte, Gobierno de Aragón E35_23RERDF/Counseling of Economic transformation, Industry, Knowledge and Universities B-BIO-84-UGR20European Union Next Generation CNS2022-135713Spanish State Research Agency, AEI PID2022-136369NB-I00Spanish State Research Agency, AEI PID2023-151100NB-I00Spanish State Research Agency, AEI RTI2018-096246-B-I00
6 · The paper itself

Abstract

Human NQO1 is a homodimeric flavoenzyme essential for the redox metabolism of many substances and implicated in major global health challenges such as cancer and Alzheimer's disease. X-ray crystallographic studies have identified several residues within its substrate binding site (including Tyr126 and Tyr128) that may regulate catalytic competent binding of substrates, cofactor redox properties, half-site reactivity, and/or functional inter-active site negative cooperativity. To elucidate the functional role of Tyr126 and Tyr128, we generated point mutants at these positions and assessed their dynamics and kinetic properties. Hydrogen-deuterium exchange coupled to mass spectrometry revealed that non-conservative mutations, particularly at Tyr126, notably disrupted dynamics not only within the substrate binding site but also in structural elements connecting the two active sites of the NQO1 homodimer. Rapid-mixing pre-steady-state kinetics experiments of the reduction of NQO1 by NAD(P)H showed that mutations to Phe caused a mild decrease in hydride transfer (HT) efficiency from the coenzyme to the FAD cofactor. In contrast, mutations to Ala resulted in a significantly greater impact and mutations to Glu nearly abolished HT. Despite these effects, some mutations moderately affected the non-synchronous catalysis between the two alternating active sites, but hardly produced an impact on the selectivity for NADPH versus NADH as hydride donor coenzymes. However, all variants exhibited markedly impaired enzyme turnover, highlighting alterations in the enzyme's substrate specificity toward quinones. The data presented here demonstrate that Tyr126 and Tyr128 optimize both substrate binding geometry as well as overall enzyme conformational dynamics during the asymmetric catalytic cycle of the NQO1 homodimer.

Indexed as

NAD(P)H Dehydrogenase (Quinone)TyrosineBinding SitesCatalytic DomainCrystallography, X-RayFlavin-Adenine DinucleotideHumansKineticsModels, MolecularMutagenesis, Site-DirectedNADPOxidation-ReductionProtein BindingProtein ConformationProtein MultimerizationSubstrate SpecificityFlavin-Adenine DinucleotideNADPNAD(P)H Dehydrogenase (Quinone)NQO1 protein, humanTyrosineasymmetric kineticscompetent substrate bindingconformational dynamicsFADhomodimeric enzymequinone oxidoreductase

Identifiers

PMID41879255
PMCPMC13534963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.